AHP Enbrel Market Expansion Plans Include Up To 2.4 Mil. U.S. Patients

The next step in Wyeth-Ayerst's plans to expand the market for Enbrel will be the presentation of the pivotal trial data in early rheumatoid arthritis during the upcoming American College of Rheumatology conference in Boston, Nov. 13-17.